Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts

The main objective of this study was the characterization of preclinical tumor models based on their expression of alpha-fetoprotein receptor (RECAF) for targeting cancer cells with a new non-coval...